Literature DB >> 9119747

Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.

Y C Yoo1, S Watanabe, R Watanabe, K Hata, K Shimazaki, I Azuma.   

Abstract

We investigated the effect of a bovine milk protein, lactoferrin (LF-B), and a pepsin-generated peptide of LF-B, lactoferricin (Lfcin-B), on inhibition of tumor metastasis produced by highly metastatic murine tumor cells, B16-BL6 melanoma and L5178Y-ML25 lymphoma cells, using experimental and spontaneous metastasis models in syngeneic mice. The subcutaneous (s.c.) administration of bovine apo-lactoferrin (apo-LF-B, 1 mg/mouse) and Lfcin-B (0.5 mg/mouse) 1 day after tumor inoculation significantly inhibited liver and lung metastasis of L5178Y-ML25 cells. However, human apolactoferrin (apo-LF-H) and bovine holo-lactoferrin (holo-LF-B) at the dose of 1 mg/mouse failed to inhibit tumor metastasis of L5178Y-ML25 cells. Similarly, the s.c. administration of apo-LF-B as well as Lfcin-B, but not apo-LF-H and holo-LF-B, 1 day after tumor inoculation resulted in significant inhibition of lung metastasis of B16-BL6 cells in an experimental metastasis model. Furthermore, in in vivo analysis for tumor-induced angiogenesis, both apo-LF-B and Lfcin-B inhibited the number of tumor-induced blood vessels and suppressed tumor growth on day 8 after tumor inoculation. However, in a long-term analysis of tumor growth for up to 21 days after tumor inoculation, single administration of apo-LF-B significantly suppressed the growth of B16-BL6 cells throughout the examination period, whereas Lfcin-B showed inhibitory activity only during the early period (8 days). In spontaneous metastasis of B16-BL6 melanoma cells, multiple administration of both apo-LF-B and Lfcin-B into tumor-bearing mice significantly inhibited lung metastasis produced by B16-BL6 cells, though only apo-LF-B exhibited an inhibitory effect on tumor growth at the time of primary tumor amputation (on day 21) after tumor inoculation. These results suggest that apo-LF-B and Lfcin-B inhibit tumor metastasis through different mechanisms, and that the inhibitory activity of LF-B on tumor metastasis may be related to iron (Fe3+)-saturation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119747      PMCID: PMC5921353          DOI: 10.1111/j.1349-7006.1997.tb00364.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  28 in total

1.  Identification of the bactericidal domain of lactoferrin.

Authors:  W Bellamy; M Takase; K Yamauchi; H Wakabayashi; K Kawase; M Tomita
Journal:  Biochim Biophys Acta       Date:  1992-05-22

2.  Comparison of bovine, sheep and goat milk lactoferrins in their electrophoretic behavior, conformation, immunochemical properties and lectin reactivity.

Authors:  K Shimazaki; N Kawano; Y C Yoo
Journal:  Comp Biochem Physiol B       Date:  1991

Review 3.  A review: the active peptide of lactoferrin.

Authors:  M Tomita; M Takase; W Bellamy; S Shimamura
Journal:  Acta Paediatr Jpn       Date:  1994-10

4.  Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes.

Authors:  B Christensen; J Fink; R B Merrifield; D Mauzerall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Identification of a mannose-acetate-specific 87-kDa receptor responsible for human NK and LAK activity.

Authors:  J Hauer; W Voetsch; F A Anderer
Journal:  Immunol Lett       Date:  1994-09       Impact factor: 3.685

6.  Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin.

Authors:  H Shau; A Kim; S H Golub
Journal:  J Leukoc Biol       Date:  1992-04       Impact factor: 4.962

7.  Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice.

Authors:  J Bezault; R Bhimani; J Wiprovnick; P Furmanski
Journal:  Cancer Res       Date:  1994-05-01       Impact factor: 12.701

8.  MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice.

Authors:  Y C Yoo; I Saiki; K Sato; I Azuma
Journal:  Vaccine       Date:  1994-02       Impact factor: 3.641

Review 9.  Iron, iron-binding proteins and immune system cells.

Authors:  M De Sousa; F Breedvelt; R Dynesius-Trentham; D Trentham; J Lum
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

10.  Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo.

Authors:  T Zagulski; P Lipiński; A Zagulska; S Broniek; Z Jarzabek
Journal:  Br J Exp Pathol       Date:  1989-12
View more
  43 in total

Review 1.  Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects.

Authors:  Amy A Baxter; Fung T Lay; Ivan K H Poon; Marc Kvansakul; Mark D Hulett
Journal:  Cell Mol Life Sci       Date:  2017-08-02       Impact factor: 9.261

Review 2.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

3.  Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.

Authors:  Joseph C Manarang; Deborah C Otteson; Alison M McDermott
Journal:  Curr Eye Res       Date:  2017-09-14       Impact factor: 2.424

4.  Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice.

Authors:  M Iigo; T Kuhara; Y Ushida; K Sekine; M A Moore; H Tsuda
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

5.  The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade.

Authors:  T Yamazaki; J M Pitt; M Vétizou; A Marabelle; C Flores; Ø Rekdal; G Kroemer; L Zitvogel
Journal:  Cell Death Differ       Date:  2016-04-15       Impact factor: 15.828

6.  Lactoferrin inhibits the inflammatory and angiogenic activation of bovine aortic endothelial cells.

Authors:  Mijung Yeom; Jongbong Park; Bombi Lee; Sang-Yun Choi; Kyoung Soo Kim; Hyejung Lee; Dae-Hyun Hahm
Journal:  Inflamm Res       Date:  2010-12-16       Impact factor: 4.575

7.  The survival of ingested lactoferrin in the gastrointestinal tract of adult mice.

Authors:  H Kuwata; T T Yip; K Yamauchi; S Teraguchi; H Hayasawa; M Tomita; T W Hutchens
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

8.  Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.

Authors:  Jamie S Mader; Daniel Smyth; Jean Marshall; David W Hoskin
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 9.  Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review.

Authors:  Arrigo F G Cicero; Federica Fogacci; Alessandro Colletti
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739

10.  Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin.

Authors:  Elaine G Rodrigues; Andrey Ss Dobroff; Clarissa F Cavarsan; Thaysa Paschoalin; Leonardo Nimrichter; Renato A Mortara; Edson Lucas Santos; Marcos A Fázio; Antonio Miranda; Sirlei Daffre; Luiz R Travassos
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.